Startups
Edit
Harm Reduction Therapeutics (HRT), Inc.
http://www.harmreductiontherapeutics.org/Last activity: 01.03.2024
Active
Mentions in press and media 3
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jul 30, 2023 | A Non-Profit Pharma Nabs FDA Nod for Non-Prescription Naloxone Nasal Spray | For the second time this year, the FDA has approved a non-prescription naloxone nasal spray to counteract the effects of opioid overdose. The latest regulatory decision is for a product from Harm Reduction Therapeutics. Harm Reduction, a no... |
| Mar 23, 2023 | Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray to Reverse Opioid Overdoses | Our company is driven by a ‘patient-first’ culture, which is synergistic with the goals and mission of our partner on this project, and we take great pride in being associated with such a potentially life-changing program. PITTSBURGH, PA an... |
Reviews 0
FAQ about Harm Reduction Therapeutics (HRT), Inc.
What has the press written about Harm Reduction Therapeutics (HRT), Inc.?
Parsers VC has collected 3 articles mentioning Harm Reduction Therapeutics (HRT), Inc., among them “A Non-Profit Pharma Nabs FDA Nod for Non-Prescription Naloxone Nasal Spray” (Jul 30, 2023) and “Harm Reduction Therapeutics and Catalent Sign Commercial Supply Agreement for Naloxone Nasal Spray to Reverse Opioid Overdoses” (Mar 23, 2023).
Is Harm Reduction Therapeutics (HRT), Inc. still active?
Yes, Harm Reduction Therapeutics (HRT), Inc. is active; its latest activity on Parsers VC dates from Mar 1, 2024.